ask="100.00"
ask_size="200"
average_daily_volume="445412"
bid="N/A"
bid_size="N/A"
book_value="11.49"
change="+0.63"
change_from_200_day_moving_average="13.54"
change_from_50_day_moving_average="9.51"
change_from_52_week_high="-5.57"
change_From_52_week_low="39.26"
change_in_percent="+0.74%"
close="85.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="87.28"
high_52_weeks="91.35"
last_trade_date="3/8/2017"
last_trade_price="85.78"
last_trade_size="23629"
last_trade_time="4:00pm"
low="84.26"
low_52_weeks="46.52"
market_capitalization="3.58B"
moving_average_200_day="72.24"
moving_average_50_day="76.27"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="85.31"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+18.75%"
percent_change_from_50_day_moving_average="+12.47%"
percent_change_from_52_week_high="-6.09%"
percent_change_from_52_week_low="+84.39%"
previous_close="85.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.41"
price_per_sales="26714.05"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="13.64"
stock_exchange="NMS"
symbol="RARE"
volume="303106"
weeks_range_52="46.52 - 91.35"
